USSTOCK.TODAY
Market Closed
Log in Sign up

Axsome Therapeutics shares drop nearly 33% ahead of Q3 earnings release

Earnings Whispers · ·by G4L

AXSM
AXSM Axsome Therapeutics Inc
$140.97 +5.23%
View chart & analysis →
  1. 1Axsome Therapeutics shares have recorded a decline of nearly 33%.
  2. 2Axsome Therapeutics' return spread against the S&P 500 is more than 31 percentage points.
  3. 3Axsome Therapeutics' consensus revenue estimate for the third quarter is $249.3 million.

So what's the key point?

Axsome Therapeutics shares have fallen significantly by about 33%. The stock price has dropped sharply while the consensus revenue estimate for the third quarter stands at $249.3 million.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Caitlin Clark signs multi-year deal with Dick's Sporting Goods and Foot Locker CNBC +3 · 6d agoAxsome Therapeutics Inc. Third Quarter Results Beat Wall Street Estimates Associated Press · Nov 2Axsome Therapeutics Reports Third Quarter Results Exceeding Expectations Earnings Whispers · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news